RESUMEN
Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a comorbidity that generally increases in people living with HIV (PLWH). This condition is usually accompanied by persistent inflammation and premature immune system aging. In this prospective cohort study, we describe a straightforward methodology for quantifying biomarkers of aging, such as DNA methylation and telomere length, in PLWH and in the context of another relevant condition, such as MAFLD. Fifty-seven samples in total, thirty-eight from PLWH and nineteen from non-PLWH participants with or without MAFLD, were obtained and subjected to DNA extraction from peripheral blood mononuclear cells (PBMCs). Global DNA methylation and telomere length quantification were performed using an adapted enzyme-linked immunosorbent assay (ELISA) and qPCR, respectively. The quantification results were analysed and corrected by clinically relevant variables in this context, such as age, sex, and metabolic syndrome. Our results show an increased association of these biomarkers in PLWH regardless of their MAFLD status. Thus, we propose including the quantification of these age-related factors in studies of comorbidities. This will allow a better understanding of the effect of comorbidities of HIV infection and MAFLD and prevent their effects in these populations in the future.
Asunto(s)
Envejecimiento Prematuro , Infecciones por VIH , Enfermedad del Hígado Graso no Alcohólico , Humanos , Metilación de ADN , Enfermedad del Hígado Graso no Alcohólico/genética , Infecciones por VIH/complicaciones , Infecciones por VIH/genética , Leucocitos Mononucleares , Estudios Prospectivos , Envejecimiento/genética , Telómero/genéticaRESUMEN
BACKGROUND: The recommended schedule for single capsule bismuth quadruple therapy (scBQT, Pylera) includes a proton pump inhibitor (PPI) two times a day and three scBQT capsules four times a day. Four times a day treatments are inconvenient and reduce adherence. In contrast, adherence improves with three times a day schedules. In clinical practice, many gastroenterologists use four capsule scBQT three times a day. However, the effectiveness and safety of this latter approach remain uncertain. AIM: To assess the effectiveness and safety of scBQT administered three times a day in the patients included in the European Registry on Helicobacter pylori Management (Hp-EuReg). METHODS: All Spanish adult patients registered in the Asociación Española de Gastroenterología Research Electronic Data Capture (REDCap) database from June 2013 to March 2021 receiving 10-day scBQT were analysed. Modified intention-to-treat effectiveness, adherence and the safety of scBQT given three times a day were calculated and compared with the four times a day schedule. A multivariate analysis was performed to determine independent factors predicting cure of the infection. RESULTS: Of the 3712 cases, 2516 (68%) were four times a day and 1196 (32%) three times a day. Mean age was 51 years, 63% were women and 15% had a peptic ulcer. The three times a day schedule showed significantly better overall cure rates than four times a day (1047/1112, 94%; 95% CI 92.7 to 95.6 vs 2207/2423, 91%; 95% CI 89.9 to 92.2, respectively, p=0.002). Adherence and safety data were similar for both regimens. In the multivariate analysis, three times a day dosage, first-line therapy, use of standard or high-dose PPIs and adherence over 90% were significantly associated with cure of the infection. CONCLUSIONS: ScBQT prescribed three times a day was more effective than the traditional four times a day schedule. No differences were observed in treatment adherence or safety.
Asunto(s)
Infecciones por Helicobacter , Helicobacter pylori , Adulto , Humanos , Femenino , Persona de Mediana Edad , Masculino , Bismuto/efectos adversos , Antibacterianos/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Quimioterapia Combinada , Metronidazol/uso terapéutico , Inhibidores de la Bomba de Protones , Sistema de Registros , Amoxicilina/uso terapéuticoRESUMEN
Dihydrosphingolipids are lipids biosynthetically related to ceramides. An increase in ceramides is associated with enhanced fat storage in the liver, and inhibition of their synthesis is reported to prevent the appearance of steatosis in animal models. However, the precise association of dihydrosphingolipids with non-alcoholic fatty liver disease (NAFLD) is yet to be established. We employed a diet induced NAFLD mouse model to study the association between this class of compounds and disease progression. Mice fed a high-fat diet were sacrificed at 22, 30 and 40 weeks to reproduce the full spectrum of histological damage found in human disease, steatosis (NAFL) and steatohepatitis (NASH) with and without significant fibrosis. Blood and liver tissue samples were obtained from patients whose NAFLD severity was assessed histologically. To demonstrate the effect of dihydroceramides over NAFLD progression we treated mice with fenretinide an inhibitor of dihydroceramide desaturase-1 (DEGS1). Lipidomic analyses were performed using liquid chromatography-tandem mass spectrometry. Triglycerides, cholesteryl esters and dihydrosphingolipids were increased in the liver of model mice in association with the degree of steatosis and fibrosis. Dihydroceramides increased with the histological severity observed in liver samples of mice (0.024 ± 0.003 nmol/mg vs 0.049 ± 0.005 nmol/mg, non-NAFLD vs NASH-fibrosis, p < 0.0001) and patients (0.105 ± 0.011 nmol/mg vs 0.165 ± 0.021 nmol/mg, p = 0.0221). Inhibition of DEGS1 induce a four-fold increase in dihydroceramides improving steatosis but increasing the inflammatory activity and fibrosis. In conclusion, the degree of histological damage in NAFLD correlate with dihydroceramide and dihydrosphingolipid accumulation. LAY SUMMARY: Accumulation of triglyceride and cholesteryl ester lipids is the hallmark of non-alcoholic fatty liver disease. Using lipidomics, we examined the role of dihydrosphingolipids in NAFLD progression. Our results demonstrate that de novo dihydrosphingolipid synthesis is an early event in NAFLD and the concentrations of these lipids are correlated with histological severity in both mouse and human disease.
Asunto(s)
Enfermedad del Hígado Graso no Alcohólico , Humanos , Animales , Ratones , Enfermedad del Hígado Graso no Alcohólico/patología , Fibrosis , Triglicéridos , CeramidasRESUMEN
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as an increasingly recognized problem among people living with HIV (PLWH). The gut-liver axis is considered to be strongly implicated in the pathogenesis of MASLD. We aimed to characterize the gut microbiota composition in PLWH and MASLD and compare it with that of two control groups: PLWH without MASLD and individuals with MASLD without HIV infection. Methods: We collected clinical data and stool samples from participants. Bacterial 16S rRNA genes were amplified, sequenced, and clustered into operational taxonomic unit. Alpha diversity was studied by Shannon and Simpson indexes. To study how different the gut microbiota composition is between the different groups, beta diversity estimation was evaluated by principal coordinate analysis (PCoA) using Bray-Curtis dissimilarity. To further analyze differences in microbiome composition we performed a linear discriminant analysis (LDA) effect size (LEfSe). Results: We included 30 HIV+MASLD+, 30 HIV+MASLD- and 20 HIV-MASLD+ participants. Major butyrate producers, including Faecalibacterium, Ruminococcus, and Lachnospira dominated the microbiota in all three groups. Shannon's and Simpson's diversity metrics were higher among MASLD+ individuals (Kruskal-Wallis p = 0.047). Beta diversity analysis showed distinct clustering in MASLD-, with MASLD+ participants overlapping regardless of HIV status (ADONIS significance <0.001). MASLD was associated with increased homogeneity across individuals, in contrast to that observed in the HIV+NAFDL- group, in which the dispersion was higher (Permanova test, p value <0.001; ANOSIM, p value <0.001). MASLD but not HIV determined a different microbiota structure (HIV+MASLD- vs. HIV+MASLD+, q-value = 0.002; HIV-MASLD+ vs. HIV+MASLD+, q-value = 0.930; and HIV-MASLD+ vs. HIV+MASLD-, q-value < 0.001). The most abundant genera in MASLD- were Prevotella, Bacteroides, Dialister, Acidaminococcos, Alloprevotella, and Catenibacterium. In contrast, the most enriched genera in MASLD+ were Ruminococcus, Streptococcus, Holdemanella, Blautia, and Lactobacillus. Conclusions: We found a microbiome signature linked to MASLD, which had a greater influence on the overall structure of the gut microbiota than HIV status alone.
Asunto(s)
Hígado Graso , Microbioma Gastrointestinal , Infecciones por VIH , Enfermedades Metabólicas , Humanos , Microbioma Gastrointestinal/genética , ARN Ribosómico 16S/genética , Clostridiales/genéticaRESUMEN
Despite its high prevalence, the mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in people living with HIV (PLWH) are still unclear. In this prospective cohort study, we aim to evaluate differences in plasma fatty acid profiles between HIV-infected and HIV-uninfected participants with NAFLD. We included participants diagnosed with NAFLD, both HIV-infected and HIV-uninfected. Fatty acid methyl esters were measured from plasma samples. Ratios ([product]/[substrate]) were used to estimate desaturases and elongases activity. We used linear regression for adjusted analyses. We included 31 PLWH and 22 HIV-uninfected controls. We did not find differences in the sum of different types of FA or in FA with a greater presence of plasma. However, there were significant differences in the distribution of some FA, with higher concentrations of ALA, trans-palmitoleic, and behenic acids, and a lower concentration of lignoceric acid in PLWH. PLWH had lower C24:0/C22:0 and C16:0/C14:0 ratios, which estimates the activity of elongases ELOVL1 and ELOVL6. Both groups had similar fatty acid distribution, despite differences in traditional risk factors. PLWH had a lower proportion of specific ratios that estimate ELOVL1 and ELOVL6 activity, which had been previously described for other inflammatory conditions, such as psoriasis.
RESUMEN
OBJECTIVE: To evaluate the use, effectiveness and safety of Helicobacter pylori empirical rescue therapy in third and subsequent treatment lines in Europe. DESIGN: International, prospective, non-interventional registry of the clinical practice of European gastroenterologists. Data were collected and quality reviewed until October 2021 at Asociación Española de Gastroenterología-Research Electronic Data Capture. All cases with three or more empirical eradication attempts were assessed for effectiveness by modified intention-to-treat and per-protocol analysis. RESULTS: Overall, 2144 treatments were included: 1519, 439, 145 and 41 cases from third, fourth, fifth and sixth treatment lines, respectively. Sixty different therapies were used; the 15 most frequently prescribed encompassed >90% of cases. Overall effectiveness remained <90% in all therapies. Optimised treatments achieved a higher eradication rate than non-optimised (78% vs 67%, p<0.0001). From 2017 to 2021, only 44% of treatments other than 10-day single-capsule therapy used high proton-pump inhibitor doses and lasted ≥14 days. Quadruple therapy containing metronidazole, tetracycline and bismuth achieved optimal eradication rates only when prescribed as third-line treatment, either as 10-day single-capsule therapy (87%) or as 14-day traditional therapy with tetracycline hydrochloride (95%). Triple amoxicillin-levofloxacin therapy achieved 90% effectiveness in Eastern Europe only or when optimised. The overall incidence of adverse events was 31%. CONCLUSION: Empirical rescue treatment in third and subsequent lines achieved suboptimal effectiveness in most European regions. Only quadruple bismuth-metronidazole-tetracycline (10-day single-capsule or 14-day traditional scheme) and triple amoxicillin-levofloxacin therapies reached acceptable outcomes in some settings. Compliance with empirical therapy optimisation principles is still poor 5 years after clinical practice guidelines update. TRIAL REGISTRATION NUMBER: NCT02328131.
RESUMEN
BACKGROUND & AIMS: Portal hypertension is the strongest predictor of hepatic decompensation and death in patients with cirrhosis. However, its discriminatory accuracy in patients with nonalcoholic fatty liver disease (NAFLD) has been challenged because hepatic vein catheterization may not reflect the real portal vein pressure as accurately as in patients with other etiologies. We aimed to evaluate the relationship between hepatic venous pressure gradient (HVPG) and presence of portal hypertension-related decompensation in patients with advanced NAFLD (aNAFLD). METHODS: Multicenter cross-sectional study included 548 patients with aNAFLD and 444 with advanced RNA-positive hepatitis C (aHCV) who had detailed portal hypertension evaluation (HVPG measurement, gastroscopy, and abdominal imaging). We examined the relationship between etiology, HVPG, and decompensation by logistic regression models. We also compared the proportions of compensated/decompensated patients at different HVPG levels. RESULTS: Both cohorts, aNAFLD and aHVC, had similar baseline age, gender, Child-Pugh score, and Model for End-Stage Liver Disease score. Median HVPG was lower in the aNAFLD cohort (13 vs 15 mmHg) despite similar liver function and higher rates of decompensation in aNAFLD group (32% vs 25%; P = .019) than in the aHCV group. For any of the HVPG cutoff analyzed (<10, 10-12, or 12 mmHg) the prevalence of decompensation was higher in the aNAFLD group than in the aHCV group. CONCLUSIONS: Patients with aNAFLD have higher prevalence of portal hypertension-related decompensation at any value of HVPG as compared with aHCV patients. Longitudinal studies aiming to identify HVPG thresholds able to predict decompensation and long-term outcomes in aNAFLD population are strongly needed.
Asunto(s)
Enfermedad Hepática en Estado Terminal , Hepatitis C , Hipertensión Portal , Enfermedad del Hígado Graso no Alcohólico , Estudios Transversales , Enfermedad Hepática en Estado Terminal/complicaciones , Hepatitis C/complicaciones , Humanos , Hipertensión Portal/etiología , Cirrosis Hepática/complicaciones , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Presión Portal , ARN , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND & AIMS: Few prospective studies have assessed the safety of direct oral anticoagulants (DOACs) in elective endoscopy. Our primary aim was to compare the risks of endoscopy-related gastrointestinal bleeding and thromboembolic events in patients on DOACs or vitamin K antagonists (VKAs) in this setting. Secondarily, we examined the impact of the timing of anticoagulant resumption on the risk of delayed bleeding in high-risk therapeutic procedures. METHODS: We conducted a multicenter, prospective, observational study from January 2018 to March 2020 of 1602 patients on oral anticoagulants (1004 on VKAs and 598 on DOACs) undergoing 1874 elective endoscopic procedures. Our primary outcomes were 90-day thromboembolic events and 30-day endoscopy-related gastrointestinal bleeding. The inverse probability of treatment weighting propensity score method was used for baseline covariate adjustment. RESULTS: The 2 groups had similar risks of endoscopy-related gastrointestinal bleeding (VKAs vs DOACs, 6.2% vs 6.7%; adjusted odds ratio [OR], 1.05; 95% CI, 0.67-1.65) and thromboembolic events (VKAs vs DOACs, 1.3% vs 1.5%; adjusted OR, 0.90; 95% CI, 0.34-2.38). In high bleeding risk procedures (n = 747), delayed anticoagulant resumption (> 48 hours or 24-48 hours vs < 24 hours) did not reduce the risk of postprocedural bleeding (10.3%, 9%, and 5.8%, respectively; adjusted P = .43). Hot and cold snare polypectomy were the most frequent high-risk interventions (41.8% and 39.8%, respectively). CONCLUSION: In a prospective study of patients on DOACs or VKAs undergoing elective endoscopy, endoscopy-related bleeding and thromboembolic events showed similar risk. Our study suggests that early anticoagulant resumption is safe in most patients, but more data are needed for advanced high-risk therapeutic procedures.
Asunto(s)
Pólipos del Colon , Administración Oral , Anticoagulantes/efectos adversos , Colonoscopía , Hemorragia Gastrointestinal/inducido químicamente , Hemorragia Gastrointestinal/epidemiología , Humanos , Estudios Prospectivos , Vitamina KRESUMEN
Introducción: El perfil profesional del instrumentador quirúrgico se basa en las competencias específicas del egresado con el fin de obtener un óptimo desempeño laboral, según su la formación académica recibida en el pregrado. Objetivo: Identificar los perfiles ocupacionales de los profesionales en Instrumentación Quirúrgica del departamento de Boyacá, Colombia, para el primer semestre del 2017. Materiales y métodos: Se realizó un estudio descriptivo de corte transversal, con una muestra de 140 profesionales en Instrumentación Quirúrgica del departamento de Boyacá, con un nivel de confianza del 95 %, en la cual se aplicó como instrumento una encuesta de 12 items. Resultados: Se observa predominio del área asistencial con un 62,1 % y soporte técnico con un 20,7 %. Así mismo, se destaca la incursión de los profesionales en las áreas de docencia, 6 %; área administrativa, 3,6 %; mercadeo y ventas, 2 %. Conclusión: En relación con los perfiles laborales de la instrumentación quirúrgica en Boyacá, predominan los profesionales que se desempeñan en el área asistencial. Esto es de suma preocupación, puesto que deja ver poco desempeño de instrumentadores en nuevos campos de acción que le den a la profesión más auge a nivel nacional e internacional.
Introduction: The profile of the surgical instrument professional is based on the specific competencies of the graduate to obtain an optimal job performance according to the academic training received in undergraduate. Objective: To identify the occupational profiles of professionals in Surgical Instrumentation in Boyacá Din Colombia for the first half of 2017. Materials and method: A descriptive cross-sectional study was carried out, with a sample of 140 professionals in surgical instrumentation from the Boyaca Department, with a 95% confidence level applying a 12-item survey test. Results: A predominance of the healthcare area is observed with 62.1% and technical support with 20.7%, likewise professionals have got a job in the areas of teaching 6%, administrative area 3.6% marketing and, sales 2%. Conclusion: Concerning the job profiles of the surgical instrument professional in Boyacá, professionals who work in the healthcare area predominate, this is of great concern since it reveals little performance of surgical instrument professionals in new fields of action that give the profession more boom At the national and international level.
RESUMEN
Introducción: El perfil profesional del instrumentador quirúrgico se basa en las competencias específicas del egresado con el fin de obtener un óptimo desempeño laboral según su la formación académica recibida en el pregrado. Objetivo. Identificar los perfiles ocupacionales de los profesionales en Instrumentación Quirúrgica del departamento de Boyacá, Colombia para el primer semestre del año 2017. Materiales y métodos. Se realizó un estudio descriptivo de corte transversal, muestra de 140 profesionales en instrumentación quirúrgica del departamento de Boyacá, con un nivel de confianza del 95% aplicando como instrumento encuesta de 12 items. Resultados: Se observa predominio del área asistencial con un 62.1 % y soporte técnico con un 20.7%, así mismo se destaca la incursión de los profesionales en las áreas de docencia 6%, área administrativa 3.6 % mercadeo y ventas 2%. Conclusión. En relación a los perfiles laborales de la Instrumentación Quirúrgica en Boyacá, predominan los profesionales que se desempeñan en el área asistencial, esto es de suma preocupación puesto que deja ver poco desempeño de Instrumentadores en nuevos campos de acción que le den a la profesión más auge a nivel nacional e internacional.
Introduction: The professional profile of the surgical instrumentator is based on the specific competencies of the graduate in order to obtain an optimal work performance according to their academic training received in the undergraduate program. Objective. To identify the occupational profiles of professionals in Surgical Instrumentation in the department of Boyacá, Colombia for the first semester of 2017. Materials and methods. A descriptive cross-sectional study was carried out, sample of 140 professionals in surgical instrumentation of the department of Boyacá, with a confidence level of 95% applying as an instrument a 12-item survey. Results: The predominance of the assistance area is observed with 62.1% and technical support with 20.7%, as well as the incursion of professionals in the areas of teaching 6%, administrative area 3.6% marketing and sales 2%. Conclusion. In relation to the labor profiles of Surgical Instrumentation in Boyacá, there is a predominance of professionals who work in the assistance area, this is of great concern since it shows little performance of Instrumentators in new fields of action that would give the profession more importance at a national and international level.
Introdução: O perfil profissional do instrumentador cirúrgico baseia-se nas competências específicas do licenciado para obter um desempenho profissional ótimo de acordo com a sua formação académica recebida ao nível da licenciatura. Objetivos. Identificar os perfis ocupacionais dos profissionais em Instrumentação Cirúrgica no departamento de Boyacá, Colômbia, para o primeiro semestre de 2017. Materiais e métodos. Foi realizado um estudo transversal descritivo, uma amostra de 140 profissionais em instrumentação cirúrgica no departamento de Boyacá, com um nível de confiança de 95%, aplicando uma pesquisa de 12 itens como instrumento. Resultados: Observa-se predominância da área assistencial com 62,1 % e apoio técnico com 20,7 %, da mesma forma a incursão de profissionais nas áreas de ensino 6%, área administrativa 3,6 % marketing e vendas 2%. Conclusões. Em relação aos perfis profissionais da Instrumentação Cirúrgica em Boyacá, há um predomínio de profissionais atuando na área assistencial, o que é muito preocupante, pois mostra pouca atuação dos profissionais da instrumentação em novos campos de atuação que dariam à profissão um maior destaque a nível nacional e internacional.
Asunto(s)
Humanos , Enfermería PerioperatoriaRESUMEN
La COVID-19 ha representado un desastre humanitario que ha conmovido a nuestros sistemas sanitarios y a la economía global. Se revisa su presentación clínica, evaluación y triaje de los pacientes estables o inestables, la toma de decisiones, las ayudas respiratorias, comorbilidades asociadas, el control de síntomas, el papel de los cuidados paliativos en esta pandemia, y la necesidad de promover un cambio en la visión y organización del mundo y la necesidad de una gobernanza mundial sanitaria a cargo de la OMS.
COVID-19 has represented an humanitarian disaster that has shaken our healthcare systems and the global economy. We review the clinic presentation, assessment and triage of stable or unstable patients, decision making, respiratory aids, intubation, associated comorbidities, symptom control, the role of palliative care and family in this pandemic, and the need to promote a change in the vision and organization of the world and the need for a global health gobernance by WHO.
Asunto(s)
Humanos , Cuidados Paliativos/métodos , Neumonía Viral/diagnóstico , Neumonía Viral/terapia , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/terapia , Neumonía Viral/clasificación , Respiración Artificial , Comorbilidad , Triaje , Infecciones por Coronavirus/clasificación , Selección de Paciente , Toma de Decisiones , PandemiasRESUMEN
BACKGROUND AND AIMS: TC-325 (Hemospray, Cook Medical, Winston-Salem, NC) is an inorganic hemostatic powder recently approved by the U.S. Food and Drug Administration. This study aimed to examine the effectiveness, safety, and predictors of TC-325 failure in a large real-life cohort. METHODS: This was a retrospective study conducted at 21 Spanish centers. All patients treated with TC-325 until September 2018 were included. The primary outcome was treatment failure, defined as failed intraprocedural hemostasis or recurrent bleeding within the first 30 postprocedural days. Secondary outcomes included safety and survival. Risk and predictors of failure were assessed via competing-risk models. RESULTS: The cohort comprised 261 patients, of whom 219 (83.9%) presented with upper gastrointestinal bleeding (GIB). The most common causes were peptic ulcer (28%), malignancy (18.4%), and therapeutic endoscopy-related GIB (17.6%). TC-325 was used as rescue therapy in 191 (73.2%) patients. The rate of intraprocedural hemostasis was 93.5% (95% confidence interval [CI], 90%-96%). Risks of TC-325 failure at postprocedural days 3, 7, and 30 were 21.1%, 24.6%, and 27.4%, respectively. On multivariate analysis, spurting bleeding (P = .004), use of vasoactive drugs (P = .02), and hypotension (P = .008) were independent predictors of failure. Overall 30-day survival was 81.9% (95% CI, 76%-86%) and intraprocedural hemostasis was associated with a better prognosis (adjusted hazard ratio, 0.29; P = .006). Two severe adverse events were noted. CONCLUSION: TC-325 was safe and effective for intraprocedural hemostasis in more than 90% of patients, regardless of the cause or site of bleeding and its use as rescue therapy. In this high-risk cohort treated with TC-325, the 30-day failure rate exceeded 25% and was highest with spurting bleeding or hemodynamic instability.
Asunto(s)
Hemorragia Gastrointestinal/tratamiento farmacológico , Hemostáticos/uso terapéutico , Minerales/uso terapéutico , Hemorragia Posoperatoria/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Endoscopía Gastrointestinal , Femenino , Hemorragia Gastrointestinal/etiología , Neoplasias Gastrointestinales/complicaciones , Hemostasis Endoscópica , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Recurrencia , Estudios Retrospectivos , Insuficiencia del TratamientoRESUMEN
Resumen Introducción. La satisfacción del usuario es considerada un componente importante en la calidad de la prestación de los servicios hospitalarios. El modelo SERVQHOS permite evaluar la percepción del usuario en los diferentes servicios. Objetivo. Identificar la percepción del usuario en relación con la calidad del servicio de cirugía ambulatoria en una institución prestadora de servicios de salud en Boyacá, Colombia. Materiales y métodos. Se realizó un estudio de tipo descriptivo y de corte transversal con un enfoque cuantitativo para analizar las dimensiones objetivas y subjetivas de la calidad en la prestación del servicio de cirugía ambulatoria. Resultados. En las variables sociodemográficas se destaca: predominio del sexo femenino, edad promedio de 47.5 años y nivel de escolaridad de bachillerato. Según la evaluación con la escala SERVQHOS, los aspectos mejor valorados por los usuarios de la calidad subjetiva son la amabilidad del personal, el trato personalizado y la confianza, mientras que en la calidad objetiva se destacan la apariencia del personal, la señalización, la tecnología y la apariencia de la infraestructura. Conclusión. La percepción del paciente sobre la calidad de los servicios se ha convertido en un factor determinante para establecer planes de mejora dentro de las actividades administrativas de las instituciones prestadoras de servicios de salud.
Abstract Introduction: User satisfaction is considered an important component of quality in the provision of medical services. The SERVQHOS model allows assessing user's perception on different services. Objective: To identify the user's perception regarding the quality of the outpatient surgical service of a healthcare institution in Boyacá, Colombia. Materials and methods: A descriptive cross-sectional study was conducted using a quantitative approach to analyze the objective and subjective dimensions of quality in outpatient surgical service delivery. Results: Sociodemographic variables include: female predominance, average age of 47.5 years, and high school educational attainment. According to the SERVQHOS Scale assessment, the aspects of subjective quality that are better rated by users are staff friendliness, personalized treatment and confidence, while objective quality emphasizes staff appearance, signposting, technology and infrastructure condition. Conclusion: The patient's perception of the quality of services has become a determining factor for establishing improvement plans within the framework of administrative activities in health care institutions.
RESUMEN
PURPOSE: The aim of this study was to evaluate the long-term efficacy and safety of the Artiflex® lens implant and to follow the evolution of the number of corneal endothelial cells over time. DESIGN: It was a retrospective study of an observational case series of patients who underwent surgery at "The INVISION Ophthalmic Hospital" (Almería, Spain) in 2007 and who were followed for 10 years. METHODS: Setting: Clinical practice. Study population included 53 eyes of 30 patients who underwent an Artiflex® lens implant for the correction of myopia from -4 to -14 D. Each patient included in this study had stable myopia for at least 2 years and a contraindication for corneal refractive surgery. The efficacy index was defined as the quotient between uncorrected distance visual acuity postoperative and best-corrected distance visual acuity (BCDVA) preoperative. The safety index was calculated as the quotient between BCDVA postop and BCDVA preop. RESULTS: The average efficacy and safety indices of the lenses implanted were 1.1 (SD 0.30) and 1.06 (SD 0.2) at 10 years of follow-up. In this period of time there has been a loss of 12% of the corneal endothelial cells. The postoperative complications were pigment dispersion in four eyes (7%) of four patients and decentration of phakic intraocular lens in two eyes (4%) of another two patients. CONCLUSIONS: The Artiflex® foldable phakic lens could be a safe and effective long-term alternative for myopic patients in whom laser surgery was contraindicated.
Asunto(s)
Implantación de Lentes Intraoculares , Miopía/cirugía , Lentes Intraoculares Fáquicas , Adulto , Recuento de Células , Pérdida de Celulas Endoteliales de la Córnea/fisiopatología , Femenino , Estudios de Seguimiento , Humanos , Presión Intraocular/fisiología , Masculino , Microscopía Acústica , Miopía/fisiopatología , Diseño de Prótesis , Refracción Ocular , Estudios Retrospectivos , Resultado del Tratamiento , Agudeza Visual/fisiologíaRESUMEN
Background: recent evidence suggests a causal link between serum uric acid and the metabolic syndrome, diabetes mellitus, arterial hypertension, and renal and cardiac disease. Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis. Aim and methods: six hundred and thirty-four patients from the nation-wide HEPAMET registry with biopsy-proven NAFLD (53% NASH) were analyzed to determine whether hyperuricemia is related with advanced liver damage in patients with non-alcoholic fatty liver disease (NAFLD). Patients were divided into three groups according to the tertile levels of serum uric acid and gender. Results: the cohort was composed of 50% females, with a mean age of 49 years (range 19-80). Patients in the top third of serum uric acid levels were older (p = 0.017); they had a higher body mass index (p < 0.01), arterial blood pressure (p = 0.05), triglyceridemia (p = 0.012), serum creatinine (p < 0.001) and total cholesterol (p = 0.016) and lower HDL-cholesterol (p = 0.004). According to the univariate analysis, the variables associated with patients in the top third were more advanced steatosis (p = 0.02), liver fibrosis (F2-F4 vs F0-1; p = 0.011), NASH (p = 0.002) and NAS score (p = 0.05). According to the multivariate logistic regression analysis, the top third of uric acid level was independently associated with steatosis (adjusted hazard ratio 1.7; CI 95%: 1.05-2.8) and NASH (adjusted hazard ratio 1.8; CI 95%: 1.08-3.0) but not with advanced fibrosis (F2-F4) (adjusted hazard ratio 1.09; CI 95%: 0.63-1.87). Conclusion: higher levels of serum uric acid were independently associated with hepatocellular steatosis and NASH in a cohort of patients with NAFLD. Serum uric acid levels warrants further evaluation as a component of the current non-invasive NAFLD scores of histopathological damage
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Hiperuricemia/complicaciones , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Hígado Graso/fisiopatología , Hipercolesterolemia/epidemiología , Hipertrigliceridemia/epidemiología , Factores de Edad , Hiperuricemia/fisiopatología , Biomarcadores/análisis , Hipercolesterolemia/complicaciones , Creatinina/sangre , Cirrosis Hepática/patología , Estudios RetrospectivosRESUMEN
BACKGROUND: recent evidence suggests a causal link between serum uric acid and the metabolic syndrome, diabetes mellitus, arterial hypertension, and renal and cardiac disease. Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis. AIM AND METHODS: six hundred and thirty-four patients from the nation-wide HEPAMET registry with biopsy-proven NAFLD (53% NASH) were analyzed to determine whether hyperuricemia is related with advanced liver damage in patients with non-alcoholic fatty liver disease (NAFLD). Patients were divided into three groups according to the tertile levels of serum uric acid and gender. RESULTS: the cohort was composed of 50% females, with a mean age of 49 years (range 19-80). Patients in the top third of serum uric acid levels were older (p = 0.017); they had a higher body mass index (p < 0.01), arterial blood pressure (p = 0.05), triglyceridemia (p = 0.012), serum creatinine (p < 0.001) and total cholesterol (p = 0.016) and lower HDL-cholesterol (p = 0.004). According to the univariate analysis, the variables associated with patients in the top third were more advanced steatosis (p = 0.02), liver fibrosis (F2-F4 vs F0-1; p = 0.011), NASH (p = 0.002) and NAS score (p = 0.05). According to the multivariate logistic regression analysis, the top third of uric acid level was independently associated with steatosis (adjusted hazard ratio 1.7; CI 95%: 1.05-2.8) and NASH (adjusted hazard ratio 1.8; CI 95%: 1.08-3.0) but not with advanced fibrosis (F2-F4) (adjusted hazard ratio 1.09; CI 95%: 0.63-1.87). CONCLUSION: higher levels of serum uric acid were independently associated with hepatocellular steatosis and NASH in a cohort of patients with NAFLD. Serum uric acid levels warrants further evaluation as a component of the current non-invasive NAFLD scores of histopathological damage.
Asunto(s)
Hiperuricemia/complicaciones , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Ácido Úrico/sangre , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Biomarcadores/sangre , Índice de Masa Corporal , Colesterol/sangre , HDL-Colesterol/sangre , Creatinina/sangre , Hígado Graso/sangre , Hígado Graso/patología , Femenino , Humanos , Hiperuricemia/sangre , Hígado/patología , Cirrosis Hepática/patología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/patología , Sistema de Registros , Estudios Retrospectivos , Factores Sexuales , Triglicéridos/sangre , Adulto JovenRESUMEN
Eosinophilic esophagitis is a chronic immunoallergic inflammatory disease of the esophagus that represents a major cause of digestive morbidity among the pediatric and young adult populations. Despite the fact that key symptoms in adults include dysphagia and food impaction, many patients lack structural changes in the esophagus to account for their complaints, which suggests the presence of underlying motor disorders and esophageal distensibility impairment. In the last few years the esophageal motility of these patients has been studied using various approaches, most particularly high-resolution manometry, ambulatory manometry, and impedance planimetry. This review focuses on the most relevant findings and scientific evidence regarding esophageal motor disorders in eosinophilic esophagitis.